Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Cancer Immunology Essentials
    • Collections
      • COVID-19 & Cancer Resource Center
      • Toolbox: Coding and Computation
      • Toolbox: Signatures and Cells
      • "Best of" Collection
      • Editors' Picks
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Immunology Research
Cancer Immunology Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Cancer Immunology Essentials
    • Collections
      • COVID-19 & Cancer Resource Center
      • Toolbox: Coding and Computation
      • Toolbox: Signatures and Cells
      • "Best of" Collection
      • Editors' Picks
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Commentaries

An unusual case of metastatic melanoma sensitive to chemotherapy and immunotherapy, with late immune escape in the brain

Verena Voelter, Alessia Pica, Julien Laurent, Donata Rimoldi, Hanifa Bouzourene, Ali Sajadi, Maurice Matter, Pedro Romero, Nathalie Rufer and Daniel E. Speiser
Verena Voelter
1Multidisciplinary Oncology Center, University of Lausanne Hospitals (CHUV), Lausanne, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alessia Pica
2Department of Radio-Oncology, CHUV, Lausanne, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Julien Laurent
3Division of Experimental Oncology, Multidisciplinary Oncology Center, CHUV, Lausanne, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Donata Rimoldi
4Division of Clinical Onco-Immunology, Ludwig Institute for Cancer Research, Lausanne Branch, Lausanne, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hanifa Bouzourene
5Department of Pathology, CHUV, Lausanne, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ali Sajadi
6Centre Universitaire Romand de Neurochirurgie, CHUV, Lausanne, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maurice Matter
7Department of Surgery, CHUV, Lausanne, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pedro Romero
4Division of Clinical Onco-Immunology, Ludwig Institute for Cancer Research, Lausanne Branch, Lausanne, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nathalie Rufer
3Division of Experimental Oncology, Multidisciplinary Oncology Center, CHUV, Lausanne, Switzerland
8Swiss National Center of Competence in Research (NCCR) Molecular Oncology, Lausanne, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel E. Speiser
4Division of Clinical Onco-Immunology, Ludwig Institute for Cancer Research, Lausanne Branch, Lausanne, Switzerland
8Swiss National Center of Competence in Research (NCCR) Molecular Oncology, Lausanne, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI:  Published January 2008
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Online Impact

Statistics from Altmetric.com

ARTICLE USAGE

ARTICLE USAGE: to

AbstractFull-text HTMLPDF
Total000

Cited By

Article Information

Volume 8, Issue 1, pp.

PubMed 
18366150

Published By 
Cancer Research Institute
Print ISSN 
1424-9634
Online ISSN 
1424-9634
History 
  • Published first January 1, 2008.

Copyright & Usage 
Copyright © 2008 by Verena Voelter

Author Information

  1. Verena Voelter1,*,
  2. Alessia Pica2,
  3. Julien Laurent3,
  4. Donata Rimoldi4,
  5. Hanifa Bouzourene5,
  6. Ali Sajadi6,
  7. Maurice Matter7,
  8. Pedro Romero4,
  9. Nathalie Rufer3,8,** and
  10. Daniel E. Speiser4,8,**
  1. 1Multidisciplinary Oncology Center, University of Lausanne Hospitals (CHUV), Lausanne, Switzerland
  2. 2Department of Radio-Oncology, CHUV, Lausanne, Switzerland
  3. 3Division of Experimental Oncology, Multidisciplinary Oncology Center, CHUV, Lausanne, Switzerland
  4. 4Division of Clinical Onco-Immunology, Ludwig Institute for Cancer Research, Lausanne Branch, Lausanne, Switzerland
  5. 5Department of Pathology, CHUV, Lausanne, Switzerland
  6. 6Centre Universitaire Romand de Neurochirurgie, CHUV, Lausanne, Switzerland
  7. 7Department of Surgery, CHUV, Lausanne, Switzerland
  8. 8Swiss National Center of Competence in Research (NCCR) Molecular Oncology, Lausanne, Switzerland
  1. Address correspondence to: Verena Voelter, MD, Celgene International, Route de Perreux 1, 2017 Boudry, Switzerland, E-mail: vvoelter{at}celgene.com
  1. ↵** These authors contributed equally to this work

  • ↵* Present address: Celgene International, Route de Perreux 1, 2017 Boudry, Switzerland

View Full Text
PreviousNext
Back to top
Cancer Immunity Archive: 8 (1)
January 2008
Volume 8, Issue 1
  • Table of Contents

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Immunology Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
An unusual case of metastatic melanoma sensitive to chemotherapy and immunotherapy, with late immune escape in the brain
(Your Name) has forwarded a page to you from Cancer Immunology Research
(Your Name) thought you would be interested in this article in Cancer Immunology Research.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
An unusual case of metastatic melanoma sensitive to chemotherapy and immunotherapy, with late immune escape in the brain
Verena Voelter, Alessia Pica, Julien Laurent, Donata Rimoldi, Hanifa Bouzourene, Ali Sajadi, Maurice Matter, Pedro Romero, Nathalie Rufer and Daniel E. Speiser
Cancer Immun January 1 2008 (8) (1) 6;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
An unusual case of metastatic melanoma sensitive to chemotherapy and immunotherapy, with late immune escape in the brain
Verena Voelter, Alessia Pica, Julien Laurent, Donata Rimoldi, Hanifa Bouzourene, Ali Sajadi, Maurice Matter, Pedro Romero, Nathalie Rufer and Daniel E. Speiser
Cancer Immun January 1 2008 (8) (1) 6;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Introduction
    • Case report
    • Correlative immunological findings
    • Discussion
    • Acknowledgments
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Translating basic mechanisms of IgG effector activity into next generation cancer therapies
  • Symmetry breaking: bispecific antibodies, the beginnings, and 50 years on
  • Introduction to monoclonal antibodies
Show more Commentaries
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Cancer Immunology Essentials

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Immunology Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Immunology Research
eISSN: 2326-6074
ISSN: 2326-6066

Advertisement